Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-01 Sale | 2024-07-03 1:15 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 405 | $22.93 | $9,287 | 71,470 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:10 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 605 | $32.99 | $19,959 | 116,542 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:44 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 4,608 | $29.5 | $135,954 | 40,845 (Direct) | View |
| 2023-07-03 Sale | 2023-07-06 3:34 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 360 | $40.51 | $14,584 | 45,146 (Direct) | View |
| 2023-06-20 Sale | 2023-06-22 5:52 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 5,000 | $45 | $225,000 | 102,896 (Direct) | View |
| 2022-07-01 Sale | 2023-01-06 5:21 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 2,028 | $37.65 | $76,357 | 14,473 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 76,302 | $0 | 116,542 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 5:52 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 5,000 | $12.27 | 102,896 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 5:52 pm | N/A 2030-02-02 | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 5,000 | $0 | 102,896 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:12 pm | N/A 2033-02-28 | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 65,347 | $0 | 79,820 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-07 7:19 pm | N/A 2032-02-28 | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 25,922 | $0 | 31,560 (Direct) | View |
Ownership | 2022-03-07 7:15 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 0 | $0 | 99,888 (Direct) | View |